Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined.Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long-term (48 weeks) low-dose azithromycin. Participants who met one of th...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Peter G. Gibson, Ian A. Yang, John W. Upham, Paul N. Reynolds, Sandra Hodge, Alan L. James, Christine Jenkins, Matthew Peters, Guy B. Marks, Melissa Baraket, Heather Powell, Jodie L. Simpson
Fformat: Artigo
Iaith:Saesneg
Cyhoeddwyd: 2019
Mynediad Ar-lein:https://doi.org/10.1183/23120541.00056-2019
https://openres.ersjournals.com/content/erjor/5/4/00056-2019.full.pdf
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!